Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
72 participants
OBSERVATIONAL
2021-05-01
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pneumonia patients with ARDS
Patients in the perioperative/intensive care setting with pneumonia-induced ARDS requiring bronchoscopy.
Bronchoscopy, blood sampling; testing.
BAL and blood samples are measured by hematology analyzer, flow cytometry, western blot, RNAseq analysis and multiplex.
Ventilated patients without ARDS
Patients without ARDS on mechanical ventilation.
Bronchoscopy, blood sampling; testing.
BAL and blood samples are measured by hematology analyzer, flow cytometry, western blot, RNAseq analysis and multiplex.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bronchoscopy, blood sampling; testing.
BAL and blood samples are measured by hematology analyzer, flow cytometry, western blot, RNAseq analysis and multiplex.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient in perioperative setting
* Age \>=18 years
* Consent
Exclusion Criteria
* Recent traumatic injury of the lung associated with (micro-)hemorrhage
* Blood aspiration
* Pregnancy
* Age\<18 years
* Acute kidney injury / Chronic kidney failure / Dialysis
* Transplantation
* HIV
* Hematologic diseases
* Immunosuppression
* Anti-Platelet-Therapy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Study Chair and Principal Investigator: Univ.-Prof. Dr. Alexander Zarbock
UNKNOWN
Principal Investigator: Dr. Andreas Margraf
UNKNOWN
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Zarbock, Univ.-Prof. Dr.
Role: STUDY_CHAIR
University Hospital Muenster
Andreas Margraf, Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Muenster
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Muenster
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Carola Wempe, Dr.
Role: primary
Andreas Margraf, Dr.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-Anit-20
Identifier Type: -
Identifier Source: org_study_id